Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $271.00 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $108.58 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $36.51 | 2 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $31.27 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $30.13 | 2 | $0 (2024) |
| Genentech USA, Inc. | $24.21 | 2 | $0 (2021) |
| Amgen Inc. | $23.09 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $17.21 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.94 | 7 | Novo Nordisk Inc ($94.85) |
| 2023 | $68.09 | 4 | IDORSIA PHARMACEUTICALS US INC ($31.27) |
| 2022 | $17.21 | 1 | GlaxoSmithKline, LLC. ($17.21) |
| 2021 | $75.76 | 5 | Merck Sharp & Dohme Corporation ($36.51) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Obesity | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Obesity | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.26 | General |
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Diabetes | ||||||
| 11/20/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Inflammation | ||||||
| 11/14/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: INSOMNIA | ||||||
| 10/13/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: INSOMNIA | ||||||
| 09/01/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Obesity | ||||||
| 01/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Virology & Specialty Care | ||||||
| 08/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/10/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Virology & Specialty Care | ||||||
About Crystal Dunn, A-GNP-BC
Crystal Dunn, A-GNP-BC is a Primary Care healthcare provider based in Rainbow City, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1417374950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Crystal Dunn, A-GNP-BC has received a total of $271.00 in payments from pharmaceutical and medical device companies, with $109.94 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($271.00).
Practice Information
- Specialty Primary Care
- Location Rainbow City, AL
- Active Since 03/21/2014
- Last Updated 11/15/2023
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1417374950
Products in Payments
- Wegovy (Drug) $55.05
- Ozempic (Drug) $38.27
- BELSOMRA (Drug) $36.51
- QUVIVIQ (Drug) $31.27
- FARXIGA (Drug) $30.13
- Xofluza (Drug) $24.21
- Otezla (Drug) $23.09
- TRELEGY ELLIPTA (Drug) $17.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.